You are here: Industry Insights > Market News > Financial Report: Roche

Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!

Note: You can unsubscribe from the alerts at any time.

Advertising

Hot Products

Propantheline Bromide

carbomer 974P

Coenzyme Q10

Refined Fish Oil

Black Currant Extract

Hydrocortisone

Financial Report: Roche

contractpharmaApril 28, 2017

Tag: Financial Report , Roche

Favorites

1Q Revenues: 12.9 million CHF (+4%)

Comments:Pharmaceuticals Division sales were 10.2 million CHF, up 3%, driven mainly by Tecentriq and Perjeta, partially offset by lower sales of Tamiflu due to generic competition. In the U.S., sales were up 6%, led by recently launched medicines Tecentriq and Alecensa, as well as Xolair and MabThera/Rituxan. In Europe sales were up +1%, with Perjeta, Actemra/RoActemra and Herceptin as the main contributors to growth. Diagnostics Division sales grew 6%, primarily due to immunodiagnostic solutions.

Previous:H&T Presspart, Hovione Technology Enter DPI Pact

Next:FDA Expands Approved Use of Stivarga (regorafenib) to Treat Hepatocellular Carcinoma

Sartorius to Advance Drug Discovery and Manufacturing with AI in Collaboration with NVIDIA

Biotech NewswireMay 17, 2024

The expanded collaboration includes increasing adoption of the NVIDIA Clara suite of AI-powered computing platforms, software, and services in the Sartorius ecosystem.

InnoCare Announces the Completion of Patient Enrollment in the Phase II Clinical Trial of ICP-488 for the Treatment of Psoriasis

PharmaSourcesMay 16, 2024

Sartorius Collaborates with Sanofi to Commercialize End-To-End Platform for Downstream Process Intensification

Biotech NewswireMay 14, 2024

Financial Report: Roche | Pharmasources.com

Touchlight Genetics and the National Physical Laboratory (NPL) Awarded Grant to Develop Novel Gene-Length Single-Stranded Genome Editing Template

Biotech NewswireMay 10, 2024

Nucleic Acid Medicines Manufacture, Round 2 call.

Financial Report: Roche

Related News

Sartorius to Advance Drug Discovery and Manufacturing with AI in Collaboration with NVIDIA

InnoCare Announces the Completion of Patient Enrollment in the Phase II Clinical Trial of ICP-488 for the Treatment of Psoriasis

Sartorius Collaborates with Sanofi to Commercialize End-To-End Platform for Downstream Process Intensification

Touchlight Genetics and the National Physical Laboratory (NPL) Awarded Grant to Develop Novel Gene-Length Single-Stranded Genome Editing Template

You may like